全文获取类型
收费全文 | 37083篇 |
免费 | 2212篇 |
国内免费 | 235篇 |
专业分类
耳鼻咽喉 | 412篇 |
儿科学 | 1018篇 |
妇产科学 | 709篇 |
基础医学 | 4963篇 |
口腔科学 | 854篇 |
临床医学 | 2889篇 |
内科学 | 9585篇 |
皮肤病学 | 894篇 |
神经病学 | 3431篇 |
特种医学 | 822篇 |
外科学 | 4690篇 |
综合类 | 326篇 |
一般理论 | 14篇 |
预防医学 | 3009篇 |
眼科学 | 815篇 |
药学 | 2381篇 |
1篇 | |
中国医学 | 172篇 |
肿瘤学 | 2545篇 |
出版年
2024年 | 38篇 |
2023年 | 360篇 |
2022年 | 927篇 |
2021年 | 1649篇 |
2020年 | 776篇 |
2019年 | 1292篇 |
2018年 | 1465篇 |
2017年 | 881篇 |
2016年 | 995篇 |
2015年 | 1189篇 |
2014年 | 1488篇 |
2013年 | 1945篇 |
2012年 | 2976篇 |
2011年 | 3095篇 |
2010年 | 1738篇 |
2009年 | 1535篇 |
2008年 | 2385篇 |
2007年 | 2378篇 |
2006年 | 2196篇 |
2005年 | 2033篇 |
2004年 | 1756篇 |
2003年 | 1590篇 |
2002年 | 1435篇 |
2001年 | 378篇 |
2000年 | 341篇 |
1999年 | 353篇 |
1998年 | 270篇 |
1997年 | 239篇 |
1996年 | 168篇 |
1995年 | 135篇 |
1994年 | 127篇 |
1993年 | 100篇 |
1992年 | 150篇 |
1991年 | 135篇 |
1990年 | 110篇 |
1989年 | 65篇 |
1988年 | 60篇 |
1987年 | 52篇 |
1986年 | 66篇 |
1985年 | 51篇 |
1984年 | 48篇 |
1983年 | 36篇 |
1982年 | 49篇 |
1981年 | 39篇 |
1980年 | 31篇 |
1979年 | 26篇 |
1978年 | 28篇 |
1977年 | 26篇 |
1974年 | 38篇 |
1973年 | 27篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
3.
4.
5.
María del Carmen Azorín Samper Marta Hernandorena Gonzlez Alberto Ibez Arias Sandra Díaz Sierra Marta Bertolo Domínguez Flix Checa Ayet 《The breast journal》2020,26(2):252-254
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment. 相似文献
6.
M.F. Werner A. López-Rueda F.X. Zarco J. Blasco L. San Román S. Amaro E. Carrero R. Valero L. Oleaga J.M. Macho N. Bargalló 《Radiologia》2019,61(2):143-152
Purpose
Endovascular treatment with mechanical thrombectomy devices demonstrated high recanalization rates but functional outcome did not correlate with high rates of recanalization obtained. Patient selection prior to the endovascular treatment is very important in the final outcome of the patient. The primary aim of our study was to evaluate the prognostic value of posterior circulation Alberta Stroke Program Early CT Score (pc-ASPECTS) and Pons-Midbrain Index (PMI) scores in patients with Basilar Artery Occlusion (BAO) treated with successful angiographic recanalization after mechanical thrombectomy.Methods
Retrospective single-center study including 18 patients between 2008 and 2013 who had acute basilar artery occlusion managed with endovascular treatment within 24 hours from symptoms onset and with successful angiographic recanalization. The patients were initially classified into two groups according to clinical outcome and mortality at 90 days. For analysis we also divided patients into groups based on pc-ASPECTS (≥8vs.< 8) and PMI (≥3vs.< 3) on non-contrast CT (NCCT) and CT Angiography Source Images (CTASI). Imaging data were correlated to clinical outcome and mortality rate.Results
CTASI pc-ASPECTS, dichotomized at < 8 versus≥8, was associated with a favorable outcome (RR: 2.6; 95% CI: 1.3-5.2) and a reduced risk of death (RR: 6.5: 95% CI: 7.8-23.3). All patients that survived and were functionally independent had pc-ASPECTS score≥8. None of the 5 patients with CTASI pc-ASPECTS score less than 8 survived.Conclusion
PC-ASPECTS on CTASI is helpful for predicting functional outcome after BAO recanalization with endovascular treatment. These results should be validated in a randomized controlled trial in order to decide whether or not to treat a patient with BAO. 相似文献7.
8.
9.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
10.